Robert P. Lenk, Director at PLUS THERAPEUTICS, INC. (PSTV), bought 3,000 shares at $2.49 ($7K) on 2020-08-25, disclosed to the SEC on 2020-08-26.
Open-market purchase of $7k PSTV by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| PSTV | BUY | 2023-11-17 | $4K | — | Filing → |
| PSTV | BUY | 2023-11-15 | $9K | — | Filing → |
| PSTV | BUY | 2023-11-13 | $15K | — | Filing → |